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Background. Lichen Planus is a chronic mucocutaneous disease of immunological basis and unknown etiology. women with oral
lichen planus may have concomitant manifestations in vulvovaginal areas. Objective.T od e t e r m i n et h ef r e q u e n c ya n dr i s kf a c t o r s
of genital involvement in a group of Iranian women aﬀected by oral lichen planus. Methods. Thirty-six women with clinical and
histopathological diagnosis of oral lichen planus were evaluated for demographic, historical, and clinical parameters of the oral
disease. All the patients were referred for careful vulvovaginal examination, as well as histopathological assessment upon clinical
indication. Results. Nineteen patients complained from genital symptoms but the number of women with the ﬁnal diagnosis of
genital lichen planus (n = 2) was too small to show any correlation with the parameters evaluated. Conclusion.I ns p i t eo fl o w
genital involvement possibly due to inadequate patient population, lack of follow-up visits, and contribution of genetic or ethnic
factors,forconservativepatientcare,womenwiththeorallichenplanusinparticularthosehavingsomerelevantgenitalsymptoms,
should preferably be referred for careful vulvovaginal examination. Multicenter cohort studies on women of diﬀerent geographical
regions or ethnicities who have genital lichen planus alone or in combination with other common sites are encouraged.
1.Introduction
Lichen Planus (LP) is an inﬂammatory disease of the strat-
iﬁed squamous epithelia with an unknown etiology [1]. LP
may involve mucosal surfaces such as the oral, genital, and
other mucosae and the skin including the scalp and nails [2].
It aﬀects most frequently the oral mucosa with the estimated
prevalence between 0.5–3%, female/male sex ratio ranging
between 1.5–3, the age of onset generally between 30 and 60
years and a premalignant potential under much debate [1].
Oral lichen planus (OLP) may manifest in six clinical forms
individually or combined: papular, reticular, plaque-like,
atrophic, erosive, and bullous. The lesions are chronic, rarely
undergo spontaneous remission, and are often a source of
morbidity [3].
Patients with OLP frequently have concomitant manifes-
tations in one or more extraoral sites [3]. The association
between LP of the vulva, vagina, and gingiva was ﬁrstly
recognized and deﬁned as vulvovaginal-gingival syndrome
[4], or plurimucosal LP [5] which thereafter was commonly
called female genital LP (GLP). It may occur as a classic form
with typical papules on the perigenital skin (labia majora)
[6] and asymptomatic reticular lesions [7], or aﬀect the
mucosal side of the vulva which is typically manifested as
a glazed erythema with possible development of secondary
erosions [6]. Various symptoms including burning, pain,2 Dermatology Research and Practice
vaginal discharge, and dyspareunia are frequent in patients
with erythematous and erosive disease [3]. Moreover, there
are the sequelae of vulval scarring and vaginal stenosis that
aﬀect sexual function [8], and may pose a small but deﬁnite
risk of malignant change [8–12].
In addition to articles delineating clinical characteristics
of the vulvovaginal-gingival syndrome [2, 7, 13–16], a
few descriptive studies in looking for possible association
between LP of oral versus female genital areas have reported
the incidence of GLP among OLP women varying between
19–58% [17–19].
OLP is one of the most common reasons for patients’
referral to our Oral Medicine Department, especially in
women. To the best of our knowledge, there has been no
report in the English language literature to give an estimate
on the frequency of GLP in Iranian women having OLP.
Therefore, we decided to perform this study to investigate
thefrequencyofgenitalinvolvementexpectedamongIranian
women with OLP and the possible association between dem-
ographic, clinical, or histological features of OLP and a high-
er risk of genital involvement.
2. Patientsand Methods
The proposal of the study was ﬁrstly reviewed and approved
bytheResearchCouncilofShirazDentalSchool,Shiraz,Iran.
FiftywomenwhoreferredconsecutivelytotheOralMedicine
Clinics of Shiraz Dental School, Shiraz, Iran, from Spring
2007 to Autumn 2009 with a preliminary clinical diagnosis
of OLP were selected to participate in our study.
The exclusion criteria were as follows: (1) any use of
systemic medications with potential suppressive eﬀect on LP
disease for at least a period of 6 months before examination;
(2) patients showing any lichen planus-like lesion in a
mucosal site in close contact or vicinity of possible causative
dental restorations particularly amalgam (naturally such a
local factor denies an etiologic role to cause the disease in
a distant site such as genitalia); (3) any history of jaundice,
or any family or occupational history that might place the
patients at risk of hepatitis C infection.
The study process and its objectives were explained to
all patients, and informed consents were obtained. Then,
the demographic, historical, and clinical data related to OLP
were recorded. During the oral examination sessions, the
patients were questioned regarding the possible existence of
pruritic cutaneous lesions of LP, as well as any of the genital
symptoms of pain, burning or pruritus, discharge, and dys-
pareunia. Then, incisional biopsy samples were taken from
the patients from a representative part of the oral lesions’
margin by one of the authors. All patients with histopath-
ological diagnosis of OLP, regardless of having genital symp-
toms or not, were referred for examination of the vulvovagi-
nal and cutaneous areas to Shahid Faghihi Polyclinic, Shiraz
University of Medical Sciences, within one week after oral
examination. At the clinic, careful vulvovaginal examination
of each referred patient was performed by the collaboration
of two authors specialized in ﬁelds of gynecology and der-
matology. At the same appointment, clinical assessment of
Figure 1: Clinical features of oral lichen planus manifested as
keratotic, atrophic, and erosive components in buccal mucosa.
Table 1: Frequency of clinical types of oral lesions in the OLP
patients.
Clinical type of OLP Number of patients (%)
Reticular 4 (11.1)
Atrophic 1 (2.8)
Reticular + atrophic 19 (52.8)
Reticular + atrophic + erosive/ulcerative 12 (33.3)
Total = 36 (100%)
OLP: oral lichen planus.
the relevant cutaneous lesions of each patient was performed
by the dermatologist. During the genital examination, an
incisional biopsy sample was taken with the patient’s consent
by the gynecologist if there were any abnormality in vulval
or vaginal sites which needed histopathological diagnosis
regardless of being related to LP or not.
In this study the modiﬁed World Health Organization’s
(WHO) diagnostic criteria of OLP proposed by van der Meij
and colleagues [20] were used for diagnostic classiﬁcation of
patients’ oral disease as well as histological diagnosis of GLP.
All data were analyzed by SPSS software, version 11.5.
Fisher’s exact test was used for comparison of the ratio of
GLP occurrences in the OLP patients of our cross-sectional
study and that of another study [19] with the same design.
P values < 0.05 were statistically signiﬁcant.
3. Results
Of the 50 women who initially enrolled in the study, 14
women refused to attend the gynecological examination for
personal reasons. In all the remaining 36 women, the set
of histopathological features of the mentioned diagnostic
criteria [20] were completely fulﬁlled by the microscopic
ﬁndings of the patients’ lesions (Figure 1). On the part of
the clinical criteria, the features of six patients were not
completelyfulﬁlled;however,becausehistologicalﬁndingsof
the six, as of the other patients were completely fulﬁlling, we
called all the patients collectively under the same diagnostic
category of OLP. Frequencies of various combinations in
the clinical types of oral lesions among 36 OLP patients are
shown in Table 1.
The patients’ ages ranged between 29 and 65 with a
mean of 49 years. The approximate duration from the ﬁrstDermatology Research and Practice 3
Table 2: Diseases and systemic medications used on a regular basis
among 36 OLP women at the initial clinical examination.
Systemic disease or condition Number of cases
Diabetes mellitus 4
Hypothyroidism 4
Mitral valve prolapse or palpitation 4
Arterial hypertension 3
Allergic disorders 2
Rheumatoid arthritis 1
Osteoporosis 1
Medication category Number of uses in
each category
Antihypertensives 8
Hormones 5
Oral hypoglycemic agents 4
Vitamin + mineral 4
NSAIDs 3
Antidepressants 3
Lipid-regulating agents 3
Insulin 2
Proton pump inhibitors 2
Bisphosphonates 1
Minor tranquilizers 1
Drugs with potential to cause LDEr∗ 12∗∗
OLP: oral lichen planus; NSAIDs: nonsteroidal anti-inﬂammatory drugs;
LDEr: lichenoid drug eruption.
∗An etiologic category of lichen planus caused by use of systemic medica-
tions.
∗∗Isolated medications with number of uses inside parentheses in 11
patients: propranolol (5), captopril (1), NSAIDs (4), and metformin (2).
presentation of the oral disease to our oral examination
session ranged from 7 days to 14 years. Upon clinical oral
examination, 24 patients (67%) complained about persistent
oral pain and discomfort at rest or when eating some kinds
of spicy or hot foods.
Review of all the patients’ records revealed that 11 (31%)
patients had recently used some medications which were
among the list of medications with known potential to cause
lichenoid or lichen planus-like drug eruptions (LDErs) [21].
Eight (22%) patients had a history of pruritic cutaneous
lesions, which had resolved either spontaneously or by
medication, but dermatological examination showed that
four (11%) patients had cutaneous LP concurrent with OLP.
The distribution of patients per disease and category of
systemic medications used on a regular basis at the time
of initial clinical examination were shown in Table 2. Also
included in the table is the row representing the medications
bearing thepotential tocauseLDEr andtheir number of uses
in the study patients.
Among the 36 OLP patients, the genital-related symp-
toms of burning or pruritus, pain, discharge, and dyspare-
unia were found in 19 (53%) patients either individually
or in combination. In the gynecological examination of the
vulvovaginal sites, clinical abnormalities were seen in four
patients for whom either excisional or incisional biopsy
samples from a representative site of the lesions’ margin were
taken. In one patient, a nonspeciﬁc thickening of skin with
Figure 2: Photomicrograph (×40) of genital lichen planus with
fulﬁllment of diagnostic histopathological criteria.
Figure 3: Vulvar lichen planus manifested as glazed erythema and
erosion of inner aspect of labia majora and labia minora around
the vaginal oriﬁce with associated atrophy, scarring, synechia, and
stenosis of vagina leading to pain and dyspareunia.
no clinical suspicion of LP was seen, which was microscopi-
cally diagnosed as a retention cyst. In another patient whose
clinical examination showed vaginal erythema and erosion,
the evaluation of the biopsy sample showed a nonspeciﬁc
inﬂammation. However, for the other two patients, as shown
in Figure 2, the diagnoses of GLP were made based on
deﬁnite histopathological criteria [20]. In both of these
patients, vulval atrophy and keratosis were clinically seen,
accompanied by vulval erosion and vaginal stenosis in one
patient who had experienced a long duration of oral as well
as genital involvements for about 14 years (Figure 3). As
shown in Table 3, because of the low number of the patients
having GLP, we were unable to perform any analysis of the
recorded parameters to estimate reliably the risk of the GLP
occurrence.
4. Discussion
In this cross-sectional study, among a group of 36 women
with OLP who were referred for vulvovaginal examination,
genital lichen planus was diagnosed in two (6%) patients4 Dermatology Research and Practice
Table 3: Distribution of historical and clinical parameters in OLP
patients based on having deﬁnite GLP or not.
Parameter or condition
Number of patients (%)
with GLP
n = 2
without GLP
n = 34
Oral symptom 2 (100) 22 (64.7)
Genital symptom 2 (100) 17 (50)
History of cutaneous LP 1 (50) 7 (20.5)
Concomitant cutaneous LP 1 (50) 3 (8.8)
Recent use of drugs with LDEr
potential 0 (0) 11 (32.3)
Oral surfaces involved
Lips 2 (100) 8 (23.5)
Labial mucosa 0 (0) 7 (20.5)
Gingival or alveolar mucosa 2 (100) 28 (82.4)
Buccal mucosa 2 (100) 27 (79.4)
Hard palate 1 (50) 7 (20.5)
S o f tp a l a t e 0( 0 ) 1( 3 )
Dorsal tongue 1 (50) 2 (6)
Ventrolateral tongue or ﬂoor of
the mouth 0 (0) 10 (29.4)
OLP: oral lichen planus; GLP: genital lichen planus; LP: lichen planus;
LDEr: lichenoid drug eruption.
based on both clinical and histopathological features. There
were no clinical abnormalities in the genital area in 32 (89%)
patients.
This ﬁnding is considerably diﬀerent from the results
of studies done in other countries with similar aims and
objectives. Eisen and colleagues [17] evaluated 399 women
with OLP over a mean period of four years and found
genital lichen planus in 77 (19%) patients only by clinical
examination. Belﬁore and coworkers [18] studied 42 women
with OLP over a period of three years. They used clinical and
histologicalexaminationsandreportedagenitalinvolvement
in 24 (57%) patients. It was not exactly stated how many
times the patients in those studies underwent gynecological
examinations for the incidences reported. However in our
study the inadequate number of the OLP patients and the
lack of gynecologic follow-up visits in the study period can
potentially weaken the reliability of comparisons between
the results of those studies and of ours. It can be assumed
that if our patients’ genital examinations were repeated over
a longer period of time, more patients with GLP could
be found. Such an assumption is consistent with a retro-
spective review on the characteristics of 122 patients with
vulvovaginal-gingival syndrome, which reported the non-
synchronous involvement of the oral and genital sites in
56.3% of patients [2].
Di Fede and colleagues [19] in a cross-sectional study
on a group of 41 OLP women which is comparable to our
sample size, reported the histopathologically proven GLP in
a statistically greater proportion of patients (24/41 = 58%)
than our study (P<0.001). It is noteworthy that on a the-
oretical basis, potential waxes and wanes in the involvement
ofthetwodiﬀerentsitesduringachronicdiseasecanpossibly
deter researchers from a true estimation on the relationship
between their occurrences. This feature has been pointed out
on the natural course of OLP in a population-based study
[22], as more or less is seen during our daily follow-up
examinations in some men or women with OLP. Whether
such the well-known waxes and wanes in course of the oral
lichen planus occur in the lichen planus of vulvovaginal
areas, needs to be investigated. It seems that cross-sectional
studies cannot give a valid and reliable estimate on the
association between LP of oral and genital areas even within
a given population of patients. However besides the factors
mentioned in explaining such the great disparities between
the genital involvements of the OLP women in our study
and those of the other comparable studies [17–19], there still
might be other important reasons.
Among the main factors responsible for the complex
etiopathogenesis of OLP [23], the role of genetic factors
on the development of some clinical subtypes of LP have
been proposed by several studies. The chance of hepatitis
C-associated OLP in patients of some geographic regions
[1], the role of genetic polymorphism of two cytokines
(IFN-γ and TNF-α) in partial determination of the oral ver-
s u so r o c u t a n e o u ss i t e so fL Pd e v e l o p m e n t[ 1], and a possible
association between the class II human leukocyte antigen
DQB1∗0201 allele and development of a severe variant of
vulvovaginal-gingival syndrome [15] are among the pro-
posed genetic factors. Hypothetically, it can also be assumed
thatthegeneticbackgroundofdiversepopulationsexamined
in diﬀerent studies along with the possible contribution of
some yet unknown disease modifying factors could manifest
GLP in a variety of frequencies and severities, regardless
of being associated with OLP or not. Establishment of
genetic studies on the GLP patients of diﬀerent ethnicities
or geographic regions can potentially clarify the role of
genetic background of the patients in development of genital
involvement in the context of either OLP patients or those
having LP in the other commonly involved sites.
In our study, genital complaints were not limited to
two patients with deﬁnite GLP, but the symptoms were also
recorded in 17 patients without GLP on genital examina-
tions. This high rate of genital symptoms could partly be at-
tributed either to atrophic mucosal changes related to meno-
pausal states, or some common inﬂammatory genital condi-
tions including fungal infection. In the case of oral mucosal
LP, eﬀects of the superimposing candidal infection and its
potential to modify the mucosal surface features of lichen
planus,orrolesofantifungaltreatmentinturningthelesion’s
altered features back to those typical of LP or in partial res-
olution of OLP and its symptoms have been reported previ-
ously [24, 25]. In this study, no attempts in looking for pos-
sible causes of the patients genital symptoms were planned.
Whether the possible role of candidal infection in our pa-
tients’ external genitalia, as of oral mucosa could have af-
fected the clinical features of a weak preexisting GLP, or have
altered the disease recognition or its presenting symp-toms,
needs further investigations on the pathogenesis of GLP.
The abundance of genital symptoms besides the low in-
cidence of deﬁnite GLP which were also symptomatic diﬀers
largely from the results of previous studies which have re-
ported higher frequencies of GLP, with a signiﬁcant minorityDermatology Research and Practice 5
of the patients having no genital symptoms [17–19]. Such
disparate results conﬁrm the fact that any association
between the occurrences of lichen planus in the two mucosal
sites could not be so straightforward as it initially seemed,
since there may be great complexities and variations in
factors responsible for the disease development and the way
it manifests in the two anatomically distinct mucosal sites.
Although our study was performed on a limited group of
OLP women and yielded a low rate of but symptomatic
genital involvement, considering even a very low possibility
for the development of SCC in the background of GLP [8–
12], a simple conclusion will advise the gynecologic exam-
ination preferably for the OLP women who complain from
genital symptoms. However noting the asymptomatic cases
in a considerable proportion of GLP patients in the other
comparable studies [17–19], our study with its limitations
and the small number of symptomatic GLP cannot reliably
deny possible existence of symptomless cases of GLP in our
community.Thereforeforconservativepatientcareanduntil
attaining a more reliable data on the genital symptom proﬁle
of the Iranian women with GLP, it seems better to refer all
OLP women for gynecological examination, regardless of the
existenceofgenitalsymptoms. However,this approachneeds
great attempts on the side of clinicians such as oral medicine
specialists or dermatologists to inform the LP patients about
their condition, course, and possible susceptibility to as-
ymptomatic genital involvement, in order to motivate them
for proper referral and examination. Gynecologists should
also be able to recognize the manifestations of GLP in close
cooperationwithdermatologistsandtomotivatethepatients
for frequent appointments for management and followup.
In this study, we confronted the unfortunate exclusion
of 14 OLP women who refused the gynecologic referral for
any reason. Some important factors may have contributed
to this noticeable fraction of undesirable patient exclusion
from the study such as diﬃculties in patients’ referrals to
distant locations in need for various clinical examinations
to be performed by diﬀerent experts and some cultural
constraints on examination of the genital sites or organs,
which vary greatly in diﬀerent people. Since in our study
the OLP patients sample size was not large enough, and the
number of patients with deﬁnite GLP was too small, we were
unable to perform any analysis of the recorded parameters to
estimate reliably the risk of the GLP occurrence. Multicentral
and long-term cohorts in patients of OLP or LP of other
common sites in diﬀerent geographical regions will lead to
a better understanding of the female GLP natural course and
promoteearlierdiseasedetectionwithagreatersuccessinthe
prevention of complications such as malignancy.
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